A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)
- Taofeek K. Owonikoko
- , Suzanne E. Dahlberg
- , Saad A. Khan
- , David E. Gerber
- , Jonathan Dowell
- , Rebecca A. Moss
- , Chandra P. Belani
- , Christine L. Hann
- , Charu Aggarwal
- , Suresh S. Ramalingam
Research output: Contribution to journal › Article › peer-review
53
Link opens in a new tab
Scopus
citations